Atlantic Healthcare to present at the Stifel 2017 Healthcare Conference in New York on November 15, 2017
8th November 2017
Cambridge, UK; November 8, 2017. Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, today announced that CEO Toby Wilson Waterworth will present at…
Atlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn’s disease and Ulcerative Colitis
30th May 2017
Existing efficacy and safety data support progress of alicaforsen targeted-release tablets into Phase 1 developmentCambridge, UK; May 30, 2017. Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a…
Atlantic Healthcare announces strengthening of the Board as it prepares for commercialisation of alicaforsen in its first indication
22nd May 2017
Eminent U.S. pharma veteran William Ringo and founding investor Andrew Boyce appointed non-executive directors; Interim Chairman Thomas Wellner takes on role permanently; Lorin Johnson steps down from BoardCambridge, UK; May 22, 2017. Atlantic…
Atlantic Healthcare initiates FDA rolling submission of its New Drug Application for alicaforsen in the treatment of pouchitis
1st May 2017
Filing of the nonclinical package marks a key milestone in the process towards obtaining marketing approval of alicaforsen for the treatment of pouchitisCambridge, UK; May 1, 2017. Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging…
Atlantic Healthcare appoints Durbin as Nordic regions distributor of alicaforsen under the Named Patient Programme
24th April 2017
Cambridge, UK, April 24, 2017. Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI) disorders, announces that is has extended its agreement with Durbin plc, for…
Atlantic Healthcare to present at TIDES Conference 2017
20th April 2017
Leadership Team available for meetings in San Diego, April 30 - May 3 Cambridge, UK; April 20, 2017. Atlantic Healthcare plc (“Atlantic Healthcare”), an emerging trans-Atlantic pharmaceutical company with a core focus on gastrointestinal (GI)…
- 1
- 2